Yahoo Web Search

Search results

1. • 

     2 Biotech Stocks to Buy in May

     Motley Fool via Yahoo Finance· 60 minutes ago

     Let's consider two such stocks in the biotech industry: Vertex Pharmaceuticals (NASDAQ: VRTX) and Regeneron Pharmaceuticals& ...

2. • Regeneron Pharmaceuticals Inc TradeGate Stock Price Today | NASDAQ REGN Live Ticker - Investing.com

     Investing.com· 1 hour ago

     Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...

3. • 

     Regeneron EVP LaRosa sells shares worth over $1.85 million By Investing.com

     Investing.com· 3 days ago

     Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) executive vice president and general...

4. • 

     Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?

     Simply Wall St. via Yahoo Finance· 3 days ago

     (NASDAQ:REGN) as an investment opportunity by taking the forecast future cash flows of the company...

5. • Dynamic Technology Lab Private Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

     ETF DAILY NEWS· 2 days ago

     Dynamic Technology Lab Private Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in ...

6. • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron ...

     NBC 10 - FOX 14 Monroe· 3 days ago

     Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (

7. • 

     After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...

     Benzinga via AOL· 21 hours ago

     U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...

8. • 

     3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

     The Motley Fool via AOL· 2 days ago

     Nvidia (NASDAQ: NVDA), Netflix (NASDAQ: NFLX), and Regeneron Pharmaceuticals (NASDAQ: REGN) have ...

9. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 2 days ago

     Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class ...

10. • Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...

      Benzinga· 5 days ago

      Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly